Calcium sulfide (CaS), a donor of hydrogen sulfide (H2S): A new antihypertensive drug?

Medical Hypotheses

Volumn 73, Issue 3, 2009, Pages 445-447

  Li, Ya Feng ^a   Xiao, Chuan Shi ^a   Hui, Ru Tai ^b,c,d,e  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d Sino German Laboratory for Molecular Medicine   (China)

^e PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM SULFIDE; GLIBENCLAMIDE; HYDROGEN SULFIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; HUMAN; HYPERTENSION; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CALCIUM COMPOUNDS; HUMANS; HYDROGEN SULFIDE; HYPERTENSION; MODELS, CARDIOVASCULAR; SULFIDES;

ANIMALIA;

EID: 67649588308     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.03.030     Document Type: Article

References (44)

1. Hajjar I., Kotchen J.M., and Kotchen T.A. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 27 (2006) 465-490
2. Grandi A.M. Antihypertensive therapy: role of aldosterone antagonists. Curr Pharm Des 11 (2005) 2235-2242
3. Brown M.J., Coltart J., Gunewardena K., et al. Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clin Sci (Lond) 107 (2004) 167-173
4. Gradman A.H., Schmieder R.E., Lins R.L., et al. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation 111 (2005) 1012-1018
5. Breschi M.C., Calderone V., Digiacomo M., et al. New no-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties. J Med Chem 49 (2006) 2628-2639
6. Balsamo A., Calderone V., and Rapposelli S. New emerging prospects in the pharmacotherapy of hypertension. Cardiovasc Hematol Agents Med Chem 6 (2008) 1-19
7. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J 16 (2002) 1792-1798
8. Stipanuk M.H., and Beck P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206 (1982) 267-277
9. Yan H., Du J., and Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313 (2004) 22-27
10. 2S) content during septic shock and endotoxin shock in rats. J Infect 47 (2003) 155-160
11. Abe K., and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16 (1996) 1066-1071
12. 2+ involvement. Immunopharmacol Immunotoxicol 19 (1997) 393-404
13. 2S as a novel endogenous gaseous KATP channel opener. J EMBO 20 (2001) 6008-6016
14. Hosoki R., Matsiki N., and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237 (1997) 527-531
15. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283 (2002) H474-H480
16. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313 (2004) 362-368
17. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322 (2008) 587-590
18. Du J., Hui Y., Cheung Y., et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 19 (2004) 75-80
19. Zhong G., Chen F., Cheng Y., et al. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21 (2003) 1879-1885
20. Chunyu Z., Junbao D., Dingfang B., et al. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 302 (2003) 810-816
21. Dombkowski R.A., Russell M.J., and Olson K.R. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 286 (2004) R678-R685
22. Cheng Y., Ndisang J.F., Tang G., et al. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287 (2004) H2316-H2323
23. Li L., Rossoni G., Sparatore A., et al. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42 (2007) 706-719
24. Wallace J.L., Caliendo G., Santagada V., et al. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132 (2007) 261-271
25. Wallace J.L. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 28 (2007) 501-505
26. Distrutti E., Sediari L., Mencarelli A., et al. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J Pharmacol Exp Ther 319 (2006) 447-458
27. Fiorucci S., Orlandi S., Mencarelli A., et al. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 150 (2007) 996-1002
28. Fiorucci S., Antonelli E., Distrutti E., et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by non steroidal anti-inflammatory drugs. Gastroenterology 129 (2005) 1210-1224
29. Hepar sulphuris calcareum (Hepar sul.) in homeopathy at .
30. Hamet P. The evaluation of the scientific evidence for a relationship between calcium and hypertension. J Nutr 125 (1995) 311S-400S
31. Griffith L.E., Guyatt G.H., Cook R.J., et al. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 12 (1999) 84-92
32. 2 oxidoreductase activity of Cu, Zn superoxide dismutase. Arch Biochem Biophys 334 (1996) 50-58
33. Picton R., Eggo M.C., Merrill G.A., et al. Mucosal protection against sulphide: importance of the enzyme rhodanese. Gut 50 (2002) 201-205
34. Levitt M.D., Furne J., Springfield J., et al. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest 104 (1999) 1107-1114
35. Li X.H., Du J.B., Bu D.F., et al. Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Acta Pharmacol Sin 27 (2006) 971-980
36. Bian J.S., Yong Q.C., Pan T.T., et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316 (2006) 670-678
37. Zhu Y.Z., Wang Z.J., Ho P., et al. Hydrogen sulfide and its cardioprotective effects in myocardial ischemia in experimental rats. J Appl Physiol 102 (2007) 261-268
38. Srilatha B., Adaikan P.G., and Moore P.K. Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction-a pilot study. Eur J Pharmacol 535 (2006) 280-282
39. Han Y., Qin J., Chang X., et al. Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats. Biochem Biophys Res Commun 327 (2005) 431-436
40. Resnick L.M. Therapeutic implications of calcium intake in hypertension: more analyses, a little progress, and a different approach. Am J Hypertens 12 (1999) 82-83
41. Cappuccio F.P. The "calcium antihypertension theory". Am J Hypertens 12 (1999) 93-95
42. Resnick L.M. The role of dietary calcium in hypertension: a hierarchical review. Am J Hypertens 12 (1999) 99-112
43. Bucher H.C., Cook R.J., Guyatt G.H., et al. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA 275 (1996) 1113-1117
44. Trumbo P.R., and Ellwood K.C. Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration. Nutr Rev 65 (2007) 78-87